apheresis

  1. leokitten

    [Case Report] Long Covid Patients Successfully Treated by Means of Heparin-Mediated Extracorporeal LDL Precipitation (H.E.L.P.) Apheresis, Jaeger 2023

    https://www.gavinpublishers.com/article/view/long-covid-patients-successfully-treated-by--means-of-heparin-mediated-extracorporeal-ldl-precipitation-help-apheresis Many COVID-19 infected patients develop a chronic state of disease that hinders them for months or even years due to severe...
  2. Andy

    A Single-Center Pilot Study of Therapeutic Apheresis in Patients with Severe Post-COVID Syndrome 2024 Korth et al

    Abstract After the COVID-19 pandemic, many patients have reported chronic fatigue and severe post-exertional malaise, with symptoms similar to those of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The accumulation of agonistic receptor autoantibodies targeting beta-adrenergic...
  3. Sly Saint

    Clinical Remission After Therapeutic Apheresis in a [ME/CFS] Patient : A Case Report, 2024, Burgard

    Clinical Remission After Therapeutic Apheresis in a Patient Suffering from Long Term Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Case Report Abstract: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating multifactorial illness characterized by...
  4. J

    “Your Blood is Black”: My ME/CFS Experience with HELP Apheresis in Germany

    https://www.healthrising.org/blog/2023/09/25/black-blood-apheresis-chronic-fatigue-syndrome/ Patrich Ussher traveled from France to Bayreuth, Germany where he underwent 7 apheresis sessions. He was told at the first session that his “blood was black” and thick – apparently a common finding in...
  5. Wyva

    Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following (...), 2023, Achleitner et al

    Full title: Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis Abstract In the aftermath of the COVID-19 pandemic, we are witnessing an unprecedented wave of post-infectious complications. Most...
  6. MSEsperanza

    Immune adsorption for the treatment of fatigue-dominant long-/post-COVID syndrome—a case series [...], 2023, Ruhe et al

    Immune adsorption for the treatment of fatigue-dominant long-/post-COVID syndrome—a case series of standardized individual experimental therapy Research letter / case series of 10 patients. Announced English version not published yet. So in lieu of an abstract here's a google translate link...
  7. Andy

    Long Covid and Apheresis – Where are we Standing?, 2022, Steenblock et al

    A continual increase in cases of Long Covid constitutes a medical and socioeconomic challenge to health systems around the globe. While the true extent of this problem cannot yet be fully evaluated, recent data suggests that up to 20% of people with confirmed with SARS-CoV-2 suffer from...
  8. Fizzlou

    Aphaeresis/ Apheresis (for removal of microclots)

    Thread split from The micro-clot finding in Long Covid — implications for the possible aetiology of ME/CFS ***************** https://www.nature.com/articles/s41380-021-01148-4 Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis? 2021
Back
Top Bottom